Contribution of Plasmid DNA to Hepatotoxicity after Systemic Administration of Lipoplexes
- 10 April 2001
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 12 (6) , 685-696
- https://doi.org/10.1089/104303401300057405
Abstract
Several studies have demonstrated that intravenous administration of DNA complexed with cationic lipid vectors induces the production of large quantities of proinflammatory cytokines. In this study we confirm these observations, using cationic lipid DOTAP and cationic phospholipid compounds. Moreover, we demonstrate that although intravenous administration of lipid–DNA complexes does not induce toxic effects in the lung, high transgene expression in lung correlates with histopathological lesions in liver, this fact being documented by high transaminase levels in serum of treated mice. We examine the contribution of various components of the lipoplexes in this observed liver toxicity, as well as in the increasing level of transaminases, and more particularly the role of nonmethylated CpG sequences of plasmid DNA. We show that blood samples from animals treated either with cationic lipid alone, or with cationic lipid complexed with methylated plasmid DNA, contain low levels of transaminases. The significant decrease in transaminase levels after injection of cationic lipid–methylated pDNA complexes leads us to believe that nonmethylated CpG sequences could play a major role in this hepatoxicity. Similar results were observed when using a vector that did not encode a transgene, demonstrating that the expression of luciferase in lung was not responsible for this liver toxicity. All these observations suggest that significant work should be devoted to understand more clearly the mechanism of cationic lipid–DNA complex toxicity, and to overcome the problems subsequent to administration of nonmethylated CpG sequences of plasmid DNA.Keywords
This publication has 23 references indexed in Scilit:
- Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungsGene Therapy, 2000
- Cationic Phosphonolipids Containing Quaternary Phosphonium and Arsonium Groups for DNA Transfection with Good Efficiency and Low Cellular Toxicity**Angewandte Chemie International Edition in English, 2000
- The Inhibitory Role of CpG Immunostimulatory Motifs in Cationic Lipid Vector-Mediated Transgene Expression in VivoHuman Gene Therapy, 1999
- Contribution of Plasmid DNA to Inflammation in the Lung after Administration of Cationic Lipid:pDNA ComplexesHuman Gene Therapy, 1999
- Direct Immunologic activities of CpG DNA and implications for gene therapyThe Journal of Gene Medicine, 1999
- Polyethylenimine-based intravenous delivery of transgenes to mouse lungGene Therapy, 1998
- Comparison between intratracheal and intravenous administration of liposome–DNA complexes for cystic fibrosis lung gene therapyGene Therapy, 1998
- Characterization of Cationic Liposome-Mediated Gene TransferIn Vivoby Intravenous AdministrationHuman Gene Therapy, 1997
- CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract.Journal of Clinical Investigation, 1997
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995